Metabolic network percolation quantifies biosynthetic capabilities across the human oral microbiome

  1. David B Bernstein
  2. Floyd E Dewhirst
  3. Daniel Segre  Is a corresponding author
  1. Boston University, United States
  2. The Forsyth Institute, United States

Abstract

The biosynthetic capabilities of microbes underlie their growth and interactions, playing a prominent role in microbial community structure. For large, diverse microbial communities, prediction of these capabilities is limited by uncertainty about metabolic functions and environmental conditions. To address this challenge, we propose a probabilistic method, inspired by percolation theory, to computationally quantify how robustly a genome-derived metabolic network produces a given set of metabolites under an ensemble of variable environments. We used this method to compile an atlas of predicted biosynthetic capabilities for 97 metabolites across 456 human oral microbes. This atlas captures taxonomically-related trends in biomass composition, and makes it possible to estimate inter-microbial metabolic distances that correlate with microbial co-occurrences. We also found a distinct cluster of fastidious/uncultivated taxa, including several Saccharibacteria (TM7) species, characterized by their abundant metabolic deficiencies. By embracing uncertainty, our approach can be broadly applied to understanding metabolic interactions in complex microbial ecosystems.

Data availability

All scripts and metabolic network data used for generating the manuscript results are available on GitHub (https://github.com/segrelab/biosynthetic_network_robustness) (f82f1e0).All genomes used to derive the metabolic networks are available from the Human Oral Microbiome Database (http://www.homd.org/), except for three strains whose genomes are available on NCBI GenBank, with the following accession numbers: Saccharibacteria (TM7) bacterium HMT-488 strain AC001: NCBI CP040003, Saccharibacteria (TM7) bacterium HMT-955 strain PM004: NCBI CP040008, Pseudopropionibacterium propionicum HMT-439 strain F0700: NCBI CP040007.The data shown in the figures are also available in the form of supplementary tables included in the manuscript submission.

The following previously published data sets were used

Article and author information

Author details

  1. David B Bernstein

    Department of Biomedical Engineering, Boston University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6091-4021
  2. Floyd E Dewhirst

    The Forsyth Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Daniel Segre

    Department of Biomedical Engineering, Boston University, Boston, United States
    For correspondence
    dsegre@bu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4859-1914

Funding

National Institute of Dental and Craniofacial Research (R37DE016937)

  • Floyd E Dewhirst

National Institute of General Medical Sciences (R01GM121950)

  • Daniel Segre

Defense Advanced Research Projects Agency (HR0011-15-C-0091)

  • Daniel Segre

Biological and Environmental Research (DE-SC0012627)

  • Daniel Segre

National Institute of Dental and Craniofacial Research (R01DE024468)

  • Floyd E Dewhirst
  • Daniel Segre

National Institute of General Medical Sciences (T32GM008764)

  • David B Bernstein

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Bernstein et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,321
    views
  • 507
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David B Bernstein
  2. Floyd E Dewhirst
  3. Daniel Segre
(2019)
Metabolic network percolation quantifies biosynthetic capabilities across the human oral microbiome
eLife 8:e39733.
https://doi.org/10.7554/eLife.39733

Share this article

https://doi.org/10.7554/eLife.39733

Further reading

    1. Computational and Systems Biology
    2. Microbiology and Infectious Disease
    Saugat Poudel, Jason Hyun ... Bernhard O Palsson
    Research Article

    The Staphylococcus aureus clonal complex 8 (CC8) is made up of several subtypes with varying levels of clinical burden; from community-associated methicillin-resistant S. aureus USA300 strains to hospital-associated (HA-MRSA) USA500 strains and ancestral methicillin-susceptible (MSSA) strains. This phenotypic distribution within a single clonal complex makes CC8 an ideal clade to study the emergence of mutations important for antibiotic resistance and community spread. Gene-level analysis comparing USA300 against MSSA and HA-MRSA strains have revealed key horizontally acquired genes important for its rapid spread in the community. However, efforts to define the contributions of point mutations and indels have been confounded by strong linkage disequilibrium resulting from clonal propagation. To break down this confounding effect, we combined genetic association testing with a model of the transcriptional regulatory network (TRN) to find candidate mutations that may have led to changes in gene regulation. First, we used a De Bruijn graph genome-wide association study to enrich mutations unique to the USA300 lineages within CC8. Next, we reconstructed the TRN by using independent component analysis on 670 RNA-sequencing samples from USA300 and non-USA300 CC8 strains which predicted several genes with strain-specific altered expression patterns. Examination of the regulatory region of one of the genes enriched by both approaches, isdH, revealed a 38-bp deletion containing a Fur-binding site and a conserved single-nucleotide polymorphism which likely led to the altered expression levels in USA300 strains. Taken together, our results demonstrate the utility of reconstructed TRNs to address the limits of genetic approaches when studying emerging pathogenic strains.

    1. Computational and Systems Biology
    Masaaki Uematsu, Jeremy M Baskin
    Tools and Resources

    Plasmid construction is central to life science research, and sequence verification is arguably its costliest step. Long-read sequencing has emerged as a competitor to Sanger sequencing, with the principal benefit that whole plasmids can be sequenced in a single run. Nevertheless, the current cost of nanopore sequencing is still prohibitive for routine sequencing during plasmid construction. We develop a computational approach termed Simple Algorithm for Very Efficient Multiplexing of Oxford Nanopore Experiments for You (SAVEMONEY) that guides researchers to mix multiple plasmids and subsequently computationally de-mixes the resultant sequences. SAVEMONEY defines optimal mixtures in a pre-survey step, and following sequencing, executes a post-analysis workflow involving sequence classification, alignment, and consensus determination. By using Bayesian analysis with prior probability of expected plasmid construction error rate, high-confidence sequences can be obtained for each plasmid in the mixture. Plasmids differing by as little as two bases can be mixed as a single sample for nanopore sequencing, and routine multiplexing of even six plasmids per 180 reads can still maintain high accuracy of consensus sequencing. SAVEMONEY should further democratize whole-plasmid sequencing by nanopore and related technologies, driving down the effective cost of whole-plasmid sequencing to lower than that of a single Sanger sequencing run.